Zai Lab Eulerpool News

Zai Lab Stock News

Zai Lab is being monitored by journalists and investors worldwide. We gather the latest Zai Lab news here.

Zai Lab Stock Press Releases

Zai Lab regularly publishes news on the company's website that are relevant for investors.

Zai Lab News 2026

This page contains all current news, analysis and press releases for Zai Lab stock (ZLAB, ISIN: US98887Q1040). This includes Eulerpool news, company analysis and official press releases. Data is updated regularly to provide investors with a complete overview of the latest developments at Zai Lab.

Zai Lab Stock

Zai Lab Zai Lab Ltd, based in Pudong, China, is a biopharmaceutical company operating in the Health Care sector. It develops and commercializes innovative treatments for oncology, immunology, neuroscience, and infectious diseases. The company offers products such as Zejula for ovarian cancer, VYVGART for myasthenia gravis, NUZYRA for bacterial infections, Optune for brain tumors, Qinlock for gastrointestinal tumors, Xacduro for bacterial pneumonia, and Augtyro for lung cancer. Zai Lab collaborates with leading pharmaceutical firms including Pfizer and Amgen.